Humacyte, Inc.
HUMA
$1.24
-$0.02-1.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.94M | -39.20M | -56.66M | -31.90M | -25.11M |
| Total Depreciation and Amortization | 1.81M | 1.81M | 1.78M | 1.79M | 1.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | -4.94M | 11.07M | 29.54M | 7.42M | 1.09M |
| Change in Net Operating Assets | -2.50M | 3.41M | 4.06M | -4.66M | 3.13M |
| Cash from Operations | -26.58M | -22.91M | -21.29M | -27.35M | -19.05M |
| Capital Expenditure | -63.00K | -934.00K | -184.00K | -391.00K | -150.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -63.00K | -934.00K | -184.00K | -391.00K | -150.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -673.00K | -659.00K | -644.00K | -603.00K | -588.00K |
| Issuance of Common Stock | 50.16M | 495.00K | 787.00K | 43.40M | 253.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.52M | 1.01M | -610.00K | 20.00M | 0.00 |
| Cash from Financing | 51.01M | 849.00K | -467.00K | 62.80M | -335.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.37M | -22.99M | -21.94M | 35.06M | -19.54M |